Novartis to the Rescue

By ACSH Staff — Jun 12, 2009
One day after the phase six pandemic alarm bells were sounded, Swiss pharmaceuticals company Novartis AG reports that it has successfully produced a first batch of swine flu vaccine using cells rather than eggs. We should be proud of these people, says ACSH s Dr. Elizabeth Whelan. They re using new technology, and they re helping people. It s the first good news we ve heard about this whole ordeal.

One day after the phase six pandemic alarm bells were sounded, Swiss pharmaceuticals company Novartis AG reports that it has successfully produced a first batch of swine flu vaccine using cells rather than eggs. We should be proud of these people, says ACSH s Dr. Elizabeth Whelan. They re using new technology, and they re helping people. It s the first good news we ve heard about this whole ordeal.

ACSH s Dr. Gilbert Ross believes that this bodes well for the approaching flu season: By the end of this year, we should have mega-doses of vaccine against swine flu in addition to the usual seasonal flu vaccines.

ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles